Michael L. Jones
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael L. Jones
Earlier roles on record: Chief Accounting Officer at Biocryst Pharmaceuticals Inc (BCRX) until July 11, 2023. Biocryst Pharmaceuticals Inc reported in an 8-K filed July 11, 2023 that Michael L. Jones resigned as Executive Director, Finance and Principal Accounting Officer.
“On July 7, 2023, Michael L. Jones, Executive Director, Finance and Principal Accounting Officer of BioCryst Pharmaceuticals, Inc. (the “Company”), informed the Company of his intention to resign from the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-08–2023-07-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.